Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Study of Glucocorticoids Combined with Belimumab in Lupus Nephritis
ChiCTR2500110869Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of belimumab in lupus nephritis (LN) (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Remission rate, Kidney function progression and 6 more. Started Oct 2025; status: completed.
02
Drugs
belimumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on ChiCTR2500110869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110869.